EDINBURGH, SCOTLAND & BOSTON--(Business Wire / Korea Newswire)--RoslinCT, a leading cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons),...